DOSIMETRIC COMPARISON OF PERMANENT PROSTATE BRACHYTHERAPY PLANS USING CS-131, I-125 AND PD-103 SEEDS

被引:0
|
作者
Yang, R. [1 ]
Wang, J. [1 ]
机构
[1] Peking Univ, Dept Radiat Oncol, Hosp 3, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1308
引用
收藏
页码:S416 / S416
页数:1
相关论文
共 50 条
  • [1] Dosimetric Comparison of Permanent Prostate Brachytherapy Plans Utilizing Cs-131, I-125 and Pd-103 Seeds
    Yang, R.
    Wang, J.
    MEDICAL PHYSICS, 2008, 35 (06)
  • [2] Dosimetric Study of Cs-131, I-125, and Pd-103 Seeds for Permanent Prostate Brachytherapy
    Yang, Ruijie
    Wang, Junjie
    Zhang, Hongzhi
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2009, 24 (06) : 701 - 705
  • [3] Is Cs-131 or I-125 or Pd-103 the "Ideal" isotope for prostate boost brachytherapy? A dosimetric view point
    Yaparpalvi, R.
    Rossinow, J.
    Cavanagh, W. A.
    Choi, W.
    Minsky, L.
    Kahan, N.
    Bodner, W.
    Garg, M.
    Kalnicki, S.
    Guha, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S677 - S678
  • [4] Dosimetric Comparison of I-125, Pd-103, and Cs-131 Seed Isotopes for Slotted Plaque Radiotherapy
    Howard, S.
    Massey, V.
    Altundal, Y.
    MEDICAL PHYSICS, 2017, 44 (06)
  • [5] Dosimetric Comparison of Cs-131 Vs. I-125 Vs. Pd-103 Intraoperative Brachytherapy in Patients with Resected Brain Metastasis
    Nedialkova, L.
    Sabbas, A.
    Trichter, S.
    Kulidzhanov, F.
    Delamerced, M.
    Parashar, B.
    Nori
    Chao, K.
    Yondorf, M.
    Wernicke, G.
    MEDICAL PHYSICS, 2013, 40 (06)
  • [6] Fractional integral target dose comparison for I-125, Pd-103 and Cs-131 in prostate seed implants
    Li, T.
    Fountain, L.
    Duff, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S566 - S567
  • [7] Producing a Look-Up Table for Mesh Brachytherapy Dosimetry with I-125, Pd-103, and Cs-131
    Grelewicz, Z.
    Cutright, D.
    Sathiaseelan, V.
    Zhang, H.
    MEDICAL PHYSICS, 2017, 44 (06)
  • [8] Toxicity Outcomes at 18 Months for Cs-131 Low-Dose-Rate Prostate Brachytherapy Compared to I-125 and Pd-103
    DePaoli, B.
    McVorran, S. M.
    Case, M. J.
    Khaleghi, S.
    Li, H.
    Marshall, D. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E218 - E218
  • [9] Pd-103 and I-125 dose comparison for delivered ocular brachytherapy plans
    Larocque, Matthew
    Weis, Ezekiel
    Menon, Geetha
    MEDICAL PHYSICS, 2017, 44 (08) : 4385 - 4386
  • [10] There is a wide range of predictive dosimetric factors for I-125 and Pd-103 prostate brachytherapy
    Herstein, Andrew
    Wallner, Kent
    Merrick, Gregory
    Orio, Peter
    Thornton, Ken
    Butler, Wayne
    Sutlief, Steven
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (01): : 6 - 10